Cite
HARVARD Citation
Sandborn, W. et al. (n.d.). DOP023 Tofacitinib for the treatment of ulcerative colitis: up to 4.4 years of safety data from global clinical trials. Journal of Crohn's and colitis. pp. S045-S046. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sandborn, W. et al. (n.d.). DOP023 Tofacitinib for the treatment of ulcerative colitis: up to 4.4 years of safety data from global clinical trials. Journal of Crohn's and colitis. pp. S045-S046. [Online].